Literature DB >> 2778716

Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.

A T Chiu1, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson, P B Timmermans.   

Abstract

A series of 1-benzylimidazole-5-acetate derivatives defining the critical substituents on the phenyl ring was synthesized in order to improve on the affinity of 2-butyl-4-chloro-1-(2-nitrobenzyl)imidazole-5-acetate, sodium (S-8308) for the angiotensin II (AII) receptor. The analogs, substituted with -1-(4-carboxybenzyl) (EXP6155),-1-[4-(2-carboxybenzamido)benzyl] (EXP6159) and the 5-methylacetate of EXP6159 (EXP6803), were found to inhibit the binding of [3H]AII to AII receptors in rat adrenal cortical microsomes with 9-, 35- and 107-fold higher affinity, respectively, than that of S-8308 (IC50, 15 X 10(-6) microM). Scatchard analysis of the [3H]AII binding revealed that in the presence of EXP6155 (10(-6) M), the dissociation constant for AII was increased from 1.2 to 3.9 X 10(-9) M, whereas the total number of binding sites remained unchanged, suggesting a competitive nature of antagonism. A similar order of affinity or potency (saralasin much greater than EXP6803 greater than EXP6159 greater than EXP6155 greater than S8308) was observed in various in vitro and in vivo assays: rat smooth muscle cells AII binding, 45Ca++ influx in rat aortic rings, contractile response in isolated rabbit aorta and AII-induced pressor response in anesthetized rats. Responses (45Ca++ and contraction) elicited by norepinephrine or by KCl were unaltered by these agents at concentrations of up to 10(-4) M. In addition, they exerted no direct effect on the activity of rabbit angiotensin converting enzyme and rat renin. In conscious renal artery-ligated rats, EXP6155, EXP6159 and EXP6803 were p.o. inactive, but caused a rapid decrease in mean arterial pressure when administered i.v.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2778716

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Regulation of angiotensin II receptors in the medullary thick ascending limb.

Authors:  D H Wang; J Li
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Characterization of AT2 receptor expression in NIH 3T3 fibroblasts.

Authors:  F M Heemskerk; S Zorad; N Xu; S J Gutkind; J M Saavedra
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

3.  Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice.

Authors:  Ivson Bezerra da Silva; Dayane Aparecida Gomes; Natalia Alenina; Michael Bader; Robson Augusto Dos Santos; Maria Luiza M Barreto-Chaves
Journal:  Heart Vessels       Date:  2017-12-07       Impact factor: 2.037

4.  Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.

Authors:  M J Robertson; J C Barnes; G M Drew; K L Clark; F H Marshall; A Michel; D Middlemiss; B C Ross; D Scopes; M D Dowle
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

5.  Purification and characterization of angiotensin II AT2 receptors from neonatal rat kidney.

Authors:  G M Ciuffo; F M Heemskerk; J M Saavedra
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.